home / stock / roiv / roiv news


ROIV News and Press, Roivant Sciences Ltd. From 02/13/24

Stock Information

Company Name: Roivant Sciences Ltd.
Stock Symbol: ROIV
Market: NASDAQ
Website: roivant.com

Menu

ROIV ROIV Quote ROIV Short ROIV News ROIV Articles ROIV Message Board
Get ROIV Alerts

News, Short Squeeze, Breakout and More Instantly...

ROIV - Roivant Sciences Ltd. (ROIV) Q3 2023 Earnings Call Transcript

2024-02-13 12:02:07 ET Roivant Sciences Ltd. (ROIV) Q3 2023 Results Conference Call February 13, 2024 08:00 AM ET Company Participants Stephanie Lee - Vice President, Special Projects Matt Gline - Chief Executive Officer Mayukh Sukhatme - President and Chief Inve...

ROIV - Roivant Sciences GAAP EPS of $6.03 beats by $5.54, revenue of $37.14M beats by $7.32M

2024-02-13 07:06:27 ET More on Roivant Sciences Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy Roivant Sciences Q3 2024 Earnings Preview Arbutus Biopharma gains after Markman heari...

ROIV - Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant completed the sale of Telavant to Roche for $7.1B with an additi...

ROIV - Expected US Company Earnings on Tuesday, February 13th, 2024

ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...

ROIV - Roivant Sciences Q3 2024 Earnings Preview

2024-02-12 12:44:03 ET More on Roivant Sciences Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute Vivek Ra...

ROIV - Notable earnings before Tuesday's open

2024-02-12 10:43:06 ET Major earnings expected before the bell on Tuesday include: Biogen ( BIIB ) Datadog ( DDOG ) The Coca-Cola ( KO ) Marriott International ( MAR ) Shopify ( SHOP ) Read the full article on Seeking Alpha For further...

ROIV - Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute

2024-02-09 14:05:35 ET More on Arbutus Biopharma Arbutus Biopharma reports 2023 cash position of ~$132M as of Dec. 31, 2023 Seeking Alpha’s Quant Rating on Arbutus Biopharma Historical earnings data for Arbutus Biopharma Financial information for Arbut...

ROIV - TOP, IMGN, SMCI, ROIV, SGOV showing five-day upward surge

2024-02-09 09:45:09 ET Topdanmark A/S (TOP) TOP is trading UP for the last 5 days, and it at trading at $6.33 with volume of 47,351,282 and a one day change of $3.06 (93.54%). Topdanmark A/S has a 52-week low of 3.56 and a 52-week high of $256.44. The business's 50-day moving averag...

ROIV - Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024

BASEL, Switzerland and LONDON and NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, February 13, 2024, to report its financial results for the third quarter ended December 31, 2023, a...

ROIV - Tourlite Capital Management Q4 2023 Investor Letter

2024-01-27 04:45:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP Founder Class returned 1.1% for the Fourth Quarter of 2023 and 8.8% for the full year. The fund has returned...

Previous 10 Next 10